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Abstract Low-level laser irradiation (LLLI) and recombi-
nant human bone morphogenetic protein type 2 (rhBMP-2)
have been used to stimulate bone formation. LLLI stimulates
proliferation of osteoblast precursor cells and cell differenti-
ation and rhBMP-2 recruits osteoprogenitor cells to the bone
healing area. This in vivo study evaluated the effects of LLLI
and rhBMP-2 on the bone healing process in rats. Critical
bone defects were created in the parietal bone in 42 animals,
and the animals were divided into six treatment groups: (1)
laser, (2) 7 μg of rhBMP-2, (3) laser and 7 μg of rhBMP-2, (4)
7 μg of rhBMP-2/monoolein gel, (5) laser and 7 μg rhBMP-2/
monoolein gel, and (6) critical bone defect controls. A
gallium-aluminum-arsenide diode laser was used (wavelength
780 nm, output power 60mW, beam area 0.04 cm2, irradiation
time 80 s, energy density 120 J/cm2, irradiance 1.5 W/cm2).
After 15 days, the calvarial tissues were removed for
histomorphometric analysis. Group 3 defects showed higher
amounts of newly formed bone (37.89%) than the defects of
all the other groups (P<0.05). The amounts of new bone in
defects of groups 1 and 4 were not significantly different
from each other (24.00% and 24.75%, respectively), but
were significantly different from the amounts in the other
groups (P<0.05). The amounts of new bone in the defects of
groups 2 and 5 were not significantly different from each
other (31.42% and 31.96%, respectively), but were
significantly different from the amounts in the other
groups (P<0.05). Group 6 defects had 14.10% new bone
formation, and this was significantly different from the
amounts in the other groups (P<0.05). It can be concluded
that LLLI administered during surgery effectively accelerated
healing of critical bone defects filled with pure rhBMP-2,
achieving a better result than LLLI alone or the use of
rhBMP-2 alone.
Keywords Low-level laser irradiation . Bone repair . Bone
morphogenetic proteins . Animals
Introduction
The use of osteogenic agents has become the target of many
investigations. Several studies, both experimental and
clinical, have investigated the effects of laser therapy on
the recovery of tissue lost for different reasons, especially
bone tissue [1]. Low-level laser irradiation (LLLI) stimulates
proliferation of osteoblast precursor cells and also cell
differentiation leading to an increase in the number of
osteoblastic cells, and consequently new bone formation [2].
There are several types of material that can be used for
bone recovery including bone grafts of different origins,
biomembranes, biomaterials with osteoconductive proper-
ties [3], and especially nowadays with the advances in
tissue engineering techniques, proteins with osteoinductive
potential, such as bone morphogenetic protein type 2
(BMP-2). This osteoinductive protein is usually used
combined with a material carrier with the aim of providing
a sustainable delivery system. An ideal carrier should
increase the exposure of host tissues to the growth factor
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substance and ensure its uniform distribution without
allowing the implanted material to exceed the site limits
and allowing it to be absorbed as bone formation occurs.
Furthermore, it should be safe, biocompatible, biodegrad-
able and formulated in different sizes and shapes for
adequate implantation [4].
Several experimental models for bone repair evaluation
using osteogenic materials have been described in the
literature, using different areas, as critical bone defects in
long bones [5], spinal cord [6], mandible [7, 8] and calvaria
[9], and involving surgical techniques such as distraction
osteogenesis [10, 11]. Thus, the aim of the present study
was to evaluate histomorphometrically the action of LLLI
and recombinant human BMP-2 (rhBMP-2) with or without
a carrier on the process of healing of critical bone defects.
Material and methods
Formulation of rhBMP-2
The rhBMP-2 (Biozentrum, Germany) was diluted 1:1 with
a neutral solution of phosphate buffer, pH 7.4. A sufficient
amount of monoolein gel at a monoolein/water ratio of 7:3
to completely cover the critical bone defect was combined
with 7 μg of protein.
Laser irradiation
The low-level laser source used was a gallium-aluminum-
arsenide (GaAlAs) semiconductor diode device (Twin-
Laser; MM Optics, São Carlos, SP, Brazil), with the laser
beam delivered via an optical fiber. The irradiation
parameters are presented in Table 1.
Animals
The animals used were 42 female Wistar rats (300–350 g
body weight, 10–12 weeks of age) from the Ribeirão Preto
Central Vivarium of the University of São Paulo. The
animals were kept under standard conditions and fed ad
libitum under an experimental protocol approved by the
Animal Care and Use Committee of the Ribeirão Preto
Campus of the University of São Paulo (protocol
08.1.224.53.6). The animals were housed in cages with
five animals in each cage, and allowed to acclimatize for
1 week before surgery. The temperature was maintained at
24±1°C with a light/dark cycle of 12/12 h with the light
period initiated at 7:00 a.m. Animals were divided into six
treatment groups of seven animals each (Table 2).
Surgical procedure
The animals were weighed and anesthetized by an intramus-
cular injection of xylazine 2% (10 mg/kg; Syntec do Brasil,
Hortolândia, São Paulo, Brazil) and ketamine 10% (75 mg/kg;
Agibrands do Brasil, Campinas, São Paulo, Brazil). Gauze
soaked in physiological saline solution (0.9%) was applied
onto both eyes during surgery to avoid corneal drying. To
expose the calvaria, a 1-cm sagittal incision was made in the
central region of the calvaria using a number 15 blade
mounted on a number 3 scalpel. The critical bone defect
(5 mm wide, 1 mm deep) was made in the right region
(parietal bone) of the exposed calvaria using just one trephine
drill (Neodent, Curitiba, PR, Brazil) for all animals. The
trephine drill was adapted to a counter-angle head with the aid
of an electric implant motor (Dentscler, Ribeirão Preto, SP,
Brazil) at 35 Ncm torque and 1,490 rpm. The depth of drilling
was controlled by a stop that was made and adapted to the
trephine drill to avoid injury to the brain of the animal. The
bone defect was made under constant irrigation with sterile
saline solution (0.9%). Immediately after creation, the critical
bone defect was irradiated according to the specified
parameters, followed by skin closure. When the rhBMP-2
protein was combined with the laser, irradiation was always
done before placement of the protein.
The animals were killed 15 days after treatment by an
intramuscular injection of xylazine 2% (10 mg/kg; Syntec
do Brasil, Hortolândia, São Paulo, Brazil) and ketamine
10% (75 mg/kg; Agibrands do Brasil, Campinas, SãoTable 1 Irradiation parameters
Parameter Value
Wavelength 780 nm (infrared)
Beam area 0.04 cm2
Output power 60 mW
Irradiation time 80 s
Energy density 120 J/cm2
Power density 1.5 W/cm2
Energy 4.8 J
Emission mode Continuous
Application In contact
Table 2 Treatment groups
Group Treatment
1 Laser in a single application
2 7 μg of pure rhBMP-2
3 Laser in a single application and 7 μg of pure rhBMP-2
4 7 μg of rhBMP-2/monoolein gel
5 laser in a single application and 7 μg of rhBMP-2/
monoolein gel
6 None (bone defect controls)
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Paulo, Brazil), followed by rupture of the diaphragm. The
animals were perfused via the heart through the left
ventricle with 0.1 M phosphate buffered saline (pH 7.4)
to wash the tissue and then with 4% formaldehyde solution
for fixation. An infusion pump (550 T2 Samtronic, Brazil)
was used to assist perfusion. The calvaria was removed
after perfusion and the soft tissues were carefully detached
from the bone. These fragments were immersed in the
perfusion fixing solution (4% formaldehyde) for 24 h and
later decalcified using 0.5 M EDTA, changing the solution
every 2 days. After decalcification, which required from 15
to 30 days, the acidity was neutralized by a 24-h treatment
in a 5% sodium sulfate solution. The tissue blocks were
dehydrated through gradual exposure to ethanol: 70%
(overnight), 80, 85, 90, 95, and 100% (2 h in each
concentration). Bone blocks were immersed in equal parts
of alcohol and xylol overnight and cleared in xylol, with
three changes each for 2 h. All blocks were then embedded
in paraffin. Semi-serial sections of thickness 6 μm were
prepared from each sample and stained with Masson’s
trichrome for later analysis under a light microscope.
Qualitative analysis by light microscopy
The light microscope (Leica DM 4000B) connected to a
digital camera (Leica EC3) was used to capture images at a
magnifications of ×10, ×20 and ×40. The newly formed
bone in the area of the critical bone defect was evaluated
qualitatively and the existing bone was differentiated from
the newly formed bone in the experimental groups.
Histomorphometric analysis
Images of the histological sections of the critical bone
defect were obtained using the microscope equipped with
the digital camera. A total of 28 sections per group were
analyzed (four per animal), this being the number sufficient
for statistical analysis. The number of sections was
calculated from the formula:
RSE ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 Vvð Þ=n
p
Where RSE is relative standard error, Vv is the volume
density of the structure under analysis, and n is the number
of points to be counted [12].
ImageJ software (http://rsb.info.nih.gov/ij) was used to
generate a grid test system consisting of horizontal and
vertical lines on each photomicrograph (Fig. 1). The points
of intersection of these lines, total 80, were counted to
determine the area of newly formed bone [13].
The volume density (Vv) of a structure can be deter-
mined by counting the points of a test system that fall on
the section of the structure [13]. The parameter used in this
study was a measure of the area of the test system occupied
by the structure, with a similar interpretation to the volume
density, as the basic law of stereology states that the
number of points that touch the structure is related to the
area of the structure between the points of the test system,
or the volume of the structure within the volume of the test
system [14].
So:
Pstr=Ptest ¼ Astr=Atest ¼ Vstr=Vtest
Where:
P number of points
A area
V volume
str analyzed structure
test test system as a whole (total)
The formula used to quantify the area of newly formed
bone was:
A ¼
X
Pstr=
X
Ptest 100ð ÞðValues in percentageÞ
Statistical analysis
A normal distribution was found for all the data (Shapiro
Wilk, P>0.05). The data were analyzed by ANOVA and
Duncan’s test to compare the groups. The SPSS (17.0)
statistical software package was used, and the significance
level was set at α=5%.
Results
Qualitative analysis
After 15 days, the bone defects treated with the laser (group
1) and the critical bone defects (group 6) exhibited a small
area of trabecular bone surrounded by osteoblasts close to
the bone defect walls. Osteocytes were observed in wide
osteocytic lacunae, indicating bone immaturity, and also
abundant organized connective tissue. The new bone tissue
in group 1 defects was more organized than that in group 6
defects (Figs. 2a, e and f). Group 5 defects (laser plus
rhBMP-2/monoolein gel) showed the same characteristics
as defects of groups 1and 6, but the amount of trabecular
bone was higher and the new bone tissue was more
organized.
In the animals treated with pure rhBMP-2 (group 2), new
trabecular bone tissue was found close to the old bone walls
with a great number of medullary cavities containing bone
marrow. Osteoblastic cells and osteocytes in lacunae were
was also evident on this trabecular bone. The adjacent
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connective tissue represented a continuation of the perios-
teum layer (Fig. 2b). This group showed the best bone tissue
organization. In the defects treated with the laser plus pure
rhBMP-2 placement (group 3) and rhBMP-2/monoolein gel
(group 4), trabecular bone formation was observed near the
old bone walls containing osteoblasts, osteocytes in lacunae,
blood vessels and connective tissue, but in group 4 defects the
amount of connective tissuewas greater. In group 3 defects the
bone tissue was more organized than in those of group 4
(Figs. 2c and d).
Quantitative analysis
The results are presented in Fig. 3 as means and standard
errors. Group 3 defects (laser and pure rhBMP-2) showed
higher amounts of newly formed bone than defects of all
the other groups (P<0.05). Defects of groups 2 (pure
rhBMP-2) and 5 (laser and rhBMP-2/monoolein gel) were
not significantly different, but were significantly different
from defects of the other groups (P<0.05). Defects of
groups 1 (laser) and 4 (rhBMP-2/monoolein gel) were not
significantly different, but were significantly different from
defects of the other groups (P<0.05). The smallest area of
new bone formation was seen in defects of group 6 (critical
bone defect control) and the difference in relation to defects
of the other groups was significant (P<0.05).
Discussion
This study aimed to evaluate the influence of LLLI and
rhBMP-2 (pure or with a carrier substrate) on healing of
calvarial bone defects in rats. LLLI and rhBMP-2 have
been reported to stimulate new bone formation [15, 16]. In
the present study, they were employed alone or in
combination using the Wistar rat as an experimental animal
model. Histomorphometric analysis revealed that defects of
group 3 (laser and pure rhBMP-2) showed the greatest area
of bone formation. The use LLLI for different treatments
and indications, such as pain control and tissue recovery,
including mineralized tissues, has been reported [17, 18].
BMPs, especially the BMP-2, have osteoinductive proper-
ties, causing mesenchymal cells to differentiate into
osteoblastic cells [19, 20].
Studies investigating the use of BMPs in association with
laser irradiation have shown similar findings, with better
results when LLLI and BMPs are combined, despite using
different experimental models [15, 21, 22] from that used in
the present work. The laser irradiation used in this study was
in continuous emission mode, but in an in vitro study, it was
observed that superpulsed laser irradiation has osteogenic
properties, inducing the expression of molecules known to be
important mediators of bone formation and, as a consequence,
increasing calcium deposition in human cells [23].
Fig. 1 The grid test with 80
points generated by ImageJ
software
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In this study, the GaAlAs diode laser in continuous mode
was used, with the following parameters: wavelength
780 nm, output power 60 mW, beam spot area 0.04 cm2,
irradiation time 80 s, energy density 120 J/cm2 and
irradiance 1.5 W/cm2. These laser parameters were chosen
because of the good results obtained in a previous study of
bone regeneration after biostimulation by LLLI and
rhBMP-2 in ovariectomized rats [16]. In addition, the
GaAlAs laser with a wavelength of 780 nm is used in
dental practice in the Faculty of Dentistry of Ribeirão Preto
of University of São Paulo (FORP/USP).
Following Pretel et al. [24], our intention was also to
establish an immediate intraoperative protocol involving a
single laser application in contact with the surgically
injured tissue, which would provide better clinical effec-
tiveness as all the energy would be delivered to the wound
area. Our aim was to confirm the beneficial effects of a
single dose of radiation to the bone defect on bone healing,
Fig. 2 a Photomicrograph of a
group 1 defect (laser) showing
the remaining bone and the
newly formed bone with small
trabeculae. b Photomicrograph
of a group 2 defect (pure
rhBMP-2) showing the newly
formed bone with a trabecular
appearance and abundant med-
ullary cavities, with bone mar-
row and connective tissue as an
extension of the periosteum lay-
er. c Photomicrograph of a
group 3 defect (laser and pure
rhBMP-2) showing the remain-
ing bone, the newly formed
bone with a trabecular appear-
ance and a small amount of
connective tissue. d Photomi-
crograph of a group 4 defect
(rhBMP-2/monoolein gel)
showing the periosteum, the
newly formed bone and the
connective tissue with blood
vessels. e Photomicrograph of a
group 5 defect (laser and
rhBMP-2/monoolein gel) show-
ing the remaining bone, the
connective tissue interspersed in
the newly formed bone and the
periosteum. f Photomicrograph
of a group 6 defect (critical bone
defect control) showing the
remaining bone, the newly
formed bone and a large amount
of organized connective tissue
(BV blood vessels, CT connec-
tive tissue, MC medullary cavi-
ties, NB newly formed bone, P
periosteum, RB remaining bone)
Fig. 3 Newly formed bone in the defects of the treatment groups
presented as mean percentages and standard errors (groups connected
by bars are not significantly different)
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seeking to show that this kind of treatment could be feasible
and could be standardized in a new faster easily applied
protocol. In the present study, when the laser was applied
alone, the presence of organizing connective tissue, with
blood capillaries and fibroblasts was observed, a result
similar to those of others [17, 24–26]. Small amounts of
trabecular bone were also observed, as found by Gerbi et al.
[21], indicating acceleration of the tissue repair process, as
reported by Ozawa et al. [2], who found an increase in cell
proliferation and differentiation after laser irradiation.
According to Karu et al. [27], the irradiation increases the
amount of ATP and cell mitotic activity.
Defects of group 5, treated with a combination of
laser and rhBMP-2 plus monoolein gel, also showed
trabecular bone, which was more organized than bone
tissue in defects of group 1. Defects of group 6 also
showed new bone tissue, but not as organized as the
new bone tissue in defects of groups 1 and 5. There
were significant differences in the amounts of new bone
tissue among the groups. In the present experimental
model, the dose used led to the formation of new bone
tissue and improved the bone healing process when
combined with rhBMP-2. The findings of the present
study agree with the results of Pretel et al. [24], who
used a GaAlAs diode laser at 178 J/cm2, Khadra et al.
[28], who used 23 J/cm2, and Renno et al. [29], who used
120 J/cm2 in ovariectomized rats.
In the present study, 7 μg of rhBMP-2 was used in
each critical bone defect. The amounts of rhBMP-2,
which aim to cover the area of the bone defect, are the
subject of much discussion in the literature, and are
dependent on several factors including the experimental
model used, the size of the bone defect and time [30–
33]. Different amounts of rhBMP-2 have been reported in
the literature [7, 9, 34, 35]. However, there is consensus
that the use of a carrier material is necessary to improve
delivery of the protein, considering that it is very
expensive and expands quickly from the site where it is
placed. Thus, the monoolein gel in cubic phase was used
as an atoxic and biodegradable matrix [36] with the ability
to incorporate different lipophilic and hydrophilic sub-
stances [37], including BMPs, and to release them
sustainably [11]. Although this vehicle has good prop-
erties as a delivery system for different substances, in
the present study, no significant differences in the
amounts of new bone tissue formed were observed
between group 2 defects (pure rhBMP-2) and group 4
defects (rhBMP-2/monoolein gel), although the new
bone tissue in group 2 defects was more organized
than that in group 4 defects.
Different periods of time for bone evaluation have
been presented in the literature, but considering the
experimental conditions of this study and the analyzed
literature, the authors decided to use 15 days until the
animals were killed to observe the initial bone healing
process response. Recent authors have found that 15, 45
and 60 days are adequate to observe new bone tissue
formation in a critical bone defect area, because these
periods correspond to the initial, medium and late bone
healing process response [24].
Conclusion
We conclude that LLLI administered during surgery
effectively accelerates healing of critical bone defects filled
with pure rhBMP-2, achieving a better result than laser
irradiation alone or the use of rhBMP-2 alone, which makes
the clinical procedure easier, faster and cheaper.
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